Design Therapeutics Stock Forecast - Naive Prediction
| DSGN Stock | USD 10.18 0.44 4.14% |
The Naive Prediction forecasted value of Design Therapeutics on the next trading day is expected to be 10.55 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.89. Design Stock Forecast is based on your current time horizon. Although Design Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Design Therapeutics' systematic risk associated with finding meaningful patterns of Design Therapeutics fundamentals over time.
As of today the rsi of Design Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (1.30) | EPS Estimate Next Year (1.30) | Wall Street Target Price 14.4 |
Using Design Therapeutics hype-based prediction, you can estimate the value of Design Therapeutics from the perspective of Design Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Design Therapeutics using Design Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Design using crowd psychology based on the activity and movement of Design Therapeutics' stock price.
Design Therapeutics Implied Volatility | 2.58 |
Design Therapeutics' implied volatility exposes the market's sentiment of Design Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Design Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Design Therapeutics stock will not fluctuate a lot when Design Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Design Therapeutics on the next trading day is expected to be 10.55 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.89. Design Therapeutics after-hype prediction price | USD 10.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Design Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Design contract
Based on the Rule 16, the options market is currently suggesting that Design Therapeutics will have an average daily up or down price movement of about 0.16% per day over the life of the 2026-04-17 option contract. With Design Therapeutics trading at USD 10.18, that is roughly USD 0.0164 . If you think that the market is fully incorporating Design Therapeutics' daily price movement you should consider acquiring Design Therapeutics options at the current volatility level of 2.58%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Design Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Design Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Design Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Design Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Design Therapeutics' open interest, investors have to compare it to Design Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Design Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Design. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Design Therapeutics Additional Predictive Modules
Most predictive techniques to examine Design price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Design using various technical indicators. When you analyze Design charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Design Therapeutics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Design Therapeutics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2020-03-31 | Previous Quarter 19.7 M | Current Value 15.1 M | Quarterly Volatility 140.5 M |
Design Therapeutics Naive Prediction Price Forecast For the 25th of January
Given 90 days horizon, the Naive Prediction forecasted value of Design Therapeutics on the next trading day is expected to be 10.55 with a mean absolute deviation of 0.30, mean absolute percentage error of 0.13, and the sum of the absolute errors of 18.89.Please note that although there have been many attempts to predict Design Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Design Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Design Therapeutics Stock Forecast Pattern
| Backtest Design Therapeutics | Design Therapeutics Price Prediction | Buy or Sell Advice |
Design Therapeutics Forecasted Value
In the context of forecasting Design Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Design Therapeutics' downside and upside margins for the forecasting period are 5.96 and 15.15, respectively. We have considered Design Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Design Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Design Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.9243 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3047 |
| MAPE | Mean absolute percentage error | 0.0352 |
| SAE | Sum of the absolute errors | 18.8912 |
Predictive Modules for Design Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Design Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Design Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Design Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Design Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Design Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Design Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Design Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Design Therapeutics' historical news coverage. Design Therapeutics' after-hype downside and upside margins for the prediction period are 5.69 and 14.53, respectively. We have considered Design Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Design Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Design Therapeutics is based on 3 months time horizon.
Design Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Design Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Design Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Design Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.73 | 4.60 | 0.07 | 0.03 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.18 | 10.11 | 0.69 |
|
Design Therapeutics Hype Timeline
Design Therapeutics is currently traded for 10.18. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of 0.03. Design is forecasted to decline in value after the next headline, with the price expected to drop to 10.11. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.69%, whereas the daily expected return is currently at 0.73%. The volatility of related hype on Design Therapeutics is about 11219.51%, with the expected price after the next announcement by competition of 10.21. About 36.0% of the company shares are held by company insiders. The book value of Design Therapeutics was currently reported as 3.51. The company recorded a loss per share of 1.19. Design Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Historical Fundamental Analysis of Design Therapeutics to cross-verify your projections.Design Therapeutics Related Hype Analysis
Having access to credible news sources related to Design Therapeutics' direct competition is more important than ever and may enhance your ability to predict Design Therapeutics' future price movements. Getting to know how Design Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Design Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AURA | Aura Biosciences | (0.12) | 8 per month | 0.00 | (0.04) | 4.74 | (5.88) | 18.08 | |
| IMAB | I Mab | 0.06 | 26 per month | 4.63 | 0.05 | 10.53 | (8.92) | 33.43 | |
| GALT | Galectin Therapeutics | 0.07 | 11 per month | 0.00 | (0.08) | 9.46 | (8.89) | 43.49 | |
| ENGN | enGene Holdings Common | (0.41) | 5 per month | 4.10 | 0.09 | 11.36 | (5.79) | 61.40 | |
| RCKT | Rocket Pharmaceuticals | 0.10 | 10 per month | 0.00 | (0.03) | 8.04 | (5.57) | 16.20 | |
| LBRX | LB Pharmaceuticals Common | 0.59 | 8 per month | 3.37 | 0.13 | 9.38 | (6.59) | 23.59 | |
| ALT | Altimmune | (0.07) | 5 per month | 4.32 | 0.10 | 9.22 | (4.73) | 33.75 | |
| ANNX | Annexon | 0.05 | 12 per month | 3.33 | 0.21 | 11.30 | (7.54) | 35.10 | |
| KRRO | Frequency Therapeutics | 0.30 | 6 per month | 0.00 | (0.09) | 10.98 | (8.07) | 91.55 | |
| DMAC | DiaMedica Therapeutics | (0.16) | 9 per month | 4.24 | 0.08 | 7.69 | (6.47) | 24.12 |
Other Forecasting Options for Design Therapeutics
For every potential investor in Design, whether a beginner or expert, Design Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Design Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Design. Basic forecasting techniques help filter out the noise by identifying Design Therapeutics' price trends.Design Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Design Therapeutics stock to make a market-neutral strategy. Peer analysis of Design Therapeutics could also be used in its relative valuation, which is a method of valuing Design Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Design Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Design Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Design Therapeutics shares will generate the highest return on investment. By undertsting and applying Design Therapeutics stock market strength indicators, traders can identify Design Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 13909.78 | |||
| Daily Balance Of Power | (0.52) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 10.55 | |||
| Day Typical Price | 10.42 | |||
| Price Action Indicator | (0.58) | |||
| Period Momentum Indicator | (0.44) |
Design Therapeutics Risk Indicators
The analysis of Design Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Design Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting design stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.8 | |||
| Semi Deviation | 3.36 | |||
| Standard Deviation | 5.16 | |||
| Variance | 26.63 | |||
| Downside Variance | 15.88 | |||
| Semi Variance | 11.32 | |||
| Expected Short fall | (4.39) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Design Therapeutics
The number of cover stories for Design Therapeutics depends on current market conditions and Design Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Design Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Design Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Design Therapeutics Short Properties
Design Therapeutics' future price predictability will typically decrease when Design Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Design Therapeutics often depends not only on the future outlook of the potential Design Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Design Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.6 M | |
| Cash And Short Term Investments | 245.5 M |
Check out Historical Fundamental Analysis of Design Therapeutics to cross-verify your projections. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.